Psychiatry

Comprehensive Summary

The study being conducted by Seker et al. aimed to examine the link between mood instability and cannabis use in adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) and depression. The study used electronic health records (EHRs) from 13,025 adolescents in the United Kingdom, specifically the UK Child and Adolescent Mental Health Services (CAMHS). Researchers used natural language processing (NLP) tools to identify mentions of mood instability and cannabis use from clinical notes. The research found that mood instability was a strong predictor of cannabis use in adolescents with either ADHD or depression, and this relationship persisted even when adjusted for socioeconomic factors. This relationship was stronger for ADHD rather than depression and a later age of diagnosis was correlated with a greater likelihood of cannabis use. Higher odds of cannabis use were also associated with a mixed ethnic background, co-occurring conditions, and being male. Overall, mood instability has been indicated to be a strong predictor for cannabis use in adolescents with ADHD as well as depression, which may help identify at-risk youth and create targeted interventions.

Outcomes and Implications

Cannabis is the most widely used recreational drug in the United Kingdom and adolescents with psychiatric conditions have much higher rates of use. These individuals with psychiatric disorders, particularly ADHD and depression, also have higher degrees of mood instability, which is a form of emotional dysregulation. These adolescents already face elevated risk for academic problems and later substance dependence, so it’s important to understand why they are vulnerable to cannabis use. The findings in this study support early intervention models, and emphasize how addressing emotional dysregulation can reduce downstream substance use. This can also help in monitoring high-risk individuals, screening earlier and more proactively, and providing faster access to care. Additionally, this research can indicate how NLP and AI can be used to extract clinically relevant information from EHR notes, which represents a shift toward precision medicine and scalable monitoring of risk factors. This study highlights how multiple psychiatric symptoms, such as hyperactivity and mood instability, can converge to put individuals at risk for cannabis use. This can help clinicians illustrate the importance of transdiagnostic traits that can help inform treatment needs.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team